LION BIOTECHNOLOGIES INC - COM (LBIO)

CUSIP: 53619R102

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
47,204,064
Share change
+5,212,854
Total reported value
$388,401,235
Put/Call ratio
144%
Price per share
$8.23
Number of holders
91
Value change
+$42,926,877
Number of buys
51
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 53619R102?
CUSIP 53619R102 identifies LBIO - LION BIOTECHNOLOGIES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q3 2016

As of 30 Sep 2016, LION BIOTECHNOLOGIES INC - COM (LBIO) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,204,064 shares. The largest 10 holders included FMR LLC, venBio Select Advisor LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, ACUTA CAPITAL PARTNERS, LLC, Broadfin Capital, LLC, VICTORY CAPITAL MANAGEMENT INC, BlackRock Fund Advisors, FRANKLIN RESOURCES INC, and VANGUARD GROUP INC. This page lists 91 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.